- This event has passed.
Cytotheryx Company Takeover
February 27 @ 8:00 am – 4:30 pm
On Feb. 27, Cytotheryx is partnering with WSU’s College of Business and College of Science & Engineering to bring industry expertise directly to the classroom for a company takeover event.
This initiative aims to connect students with real-world applications of their studies in marketing, accounting, medical sciences, and more to offer a unique opportunity to learn from professionals at the forefront of innovation.
Event Agenda
- Guest Lectures
- Interactive Case Study or Q&A Sessions
- Networking and Career Insights
- Lunch & Learn
About Cytotheryx
Cytotheryx, Inc., is an emerging biotechnology company specializing in developing a consistent and high-quality source of primary human hepatocytes (liver cells) to advance research and therapeutic applications. Their work addresses a critical need in medicine because current supplies of human hepatocytes are limited, inconsistent, and dependent on organ donations.
Cytotheryx’ proprietary platform enables scalable production of these cells for various uses, including drug metabolism studies, disease modeling, and regenerative medicine. On the clinical side, their innovations support treatments like cell therapy, bioartificial liver devices, and hepatocyte transplantation, harnessing the scalable supply of hepatocytes to transform care for acute, chronic, and rare forms of liver disease.
Their mission is grounded in values like innovation, responsibility, and ethical research, aiming to create life-changing solutions for millions affected by liver diseases. Cytotheryx collaborates with key partners, including Mayo Clinic, to expand the applications of their technology.
